Here comes the huge shakeout before meeting. Sure things could get worse before they get better, but May is a long time away. IMO NWBO knows what they have, but just don’t know how to monetize, until approvals start coming in.
Bold 1): If you call being down 1.60% a "shake-out" you clearly haven't been investing in stocks all that long.
Bold 2): Is May really "a long time way".....5 months in the biotech world is equal to about 2 weeks normally time. If its May than so but it, but suspect your time-line is off by about 2 months.
Bold 3): Isnt the whole "monetize" issue with any biotech directly related to a approved, commercially available product? Unless there are other ways to monetize a drug without approval?.....am I unaware?? Please enlighten me. Of course NW Bio knows what they have, and they surly know how to "motenize" it....with approvals. Which is being worked on as week speak.
I also suspect a merger between Advent and NW Bio may be in the cards. You need to account for all shares during a merger and counterfeits will be exposed, big-time. See how this works??
This whole post if filled with noting but BS that flys in the face of logic, plain and simple. I suggest you might want to re-think your thinking and post something based on facts and at least sound knowledgeable with the subject matter.